Current Report Filing (8-k)
July 11 2014 - 12:14PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July
10, 2014
RESPONSE
GENETICS, INC.
(Exact name of registrant as specified in its charter)
Delaware |
|
1-33509 |
|
11-3525548 |
(State or other |
|
(Commission File |
|
(IRS Employer |
jurisdiction of |
|
Number) |
|
Identification No.) |
incorporation) |
|
|
|
|
1640 Marengo St., 7th Floor
Los Angeles, California 90033
(323) 224-3900
(Address, including zip code, and telephone
number, including area code, of registrant’s principal executive offices)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.07. Submission
of Matters to a Vote of Security Holders.
On July 10, 2014, Response Genetics, Inc.
(the “Company”) held an annual meeting of its stockholders (the “2014 Annual Meeting”). A
total of 32,070,160 shares of the Company’s common stock, par value $0.01 per share, (“Common Stock”) were
present or represented by proxy at the meeting, representing approximately 82.79% of the outstanding Common Stock as of May 12,
2014, the record date for the 2014 Annual Meeting.
At the 2014 Annual Meeting, three proposals
were submitted for a vote of the Company’s stockholders and the related results are as follows:
Proposal 1. The election of Thomas
A. Bologna, Kirk K. Calhoun, Sam Chawla, David R. Schreiber, Michael Serruya, Richard van den Broek and David Wurzer as directors
until the next succeeding annual meeting of stockholders of the Company or until each such director’s successor shall have
been duly elected and qualified. The stockholders elected the seven directors by the following votes:
Name of Nominee | |
Votes For: | | |
Withheld: | |
| |
| | |
| |
01) Thomas A. Bologna | |
| 23,419,250 | | |
| 96,419 | |
| |
| | | |
| | |
02) Kirk K. Calhoun | |
| 23,405,347 | | |
| 110,322 | |
| |
| | | |
| | |
03) Sam Chawla | |
| 23,410,047 | | |
| 105,622 | |
| |
| | | |
| | |
04) David R. Schreiber | |
| 23,412,347 | | |
| 103,322 | |
| |
| | | |
| | |
05) Michael Serruya | |
| 22,573,297 | | |
| 942,372 | |
| |
| | | |
| | |
06) Richard van den Broek | |
| 23,411,847 | | |
| 103,822 | |
| |
| | | |
| | |
07) David M. Wurzer | |
| 23,405,347 | | |
| 110,322 | |
Broker Non-Votes: 8,554,491
Proposal 2. The ratification
of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending
December 31, 2014. The stockholders ratified BDO USA, LLP by the following votes:
Votes For |
|
Votes Against |
|
Votes Abstained |
|
|
|
|
|
31,301,193 |
|
546,298 |
|
222,669 |
Proposal 3. Amendment of the
Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares of the Company’s Common
Stock from 50 million to 70 million shares. The stockholders approved the proposed amendment by the following votes:
Votes For |
|
Votes Against |
|
Votes Abstained |
|
|
|
|
|
29,305,095 |
|
2,721,129 |
|
43,936 |
SIGNATURES
Pursuant to the
requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its
behalf by the undersigned hereunto duly authorized.
|
RESPONSE GENETICS, INC. |
|
|
|
Date: July 11, 2014 |
By: |
/s/ Adanech Getachew |
|
Name: |
Adanech Getachew |
|
Title: |
General Counsel |
Response Genetics (CE) (USOTC:RGDXQ)
Historical Stock Chart
From Jun 2024 to Jul 2024
Response Genetics (CE) (USOTC:RGDXQ)
Historical Stock Chart
From Jul 2023 to Jul 2024